Home Careers Contact

Price: 3.80

Change: - 0.08

Day High: 3.95
Day Low: 3.75
Volume: 435,930

4:00 PM ET | Apr 21, 2017
Delayed 20 min., by eSignal.

Shareholder Tools

Investor Relations

Cempra, Inc. is a clinical-stage pharmaceutical company focused on developing antibacterials to meet critical medical needs. Two lead antibacterial products, both in the treatment of infectious diseases, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community.

View all »Events & Presentations

Apr 28, 2017 at 8:45 AM ET
Cempra Inc. First Quarter 2017 Financial and Operating Results